During the past decade, Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bayer" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Brazilian Society of Head and Neck Surgery" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are "Head and Neck Cancer" (2 trials), "Prostatic Neoplasms" (2 trials), "Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials) and "BRCA Mutation" (1 trials). Many other conditions were trialed in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" in a lesser frequency.

Most popular intervention types in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are "Drug" (14 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Olaparib 300mg tablets" (2 trials), "Placebo" (2 trials), "Abiraterone acetate (AA)" (1 trials) and "Androgen Deprivation Therapy (ADT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge" are 9 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".